A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis
Journal of the American Society of Nephrology | Feb 10, 2020
Most read this week
Journal of the American Society of Nephrology | Feb 10, 2020